Article

(2023) Putative Therapeutic Impact of Inflammasome Inhibitors against COVID-19-Induced ARDS. Current medicinal chemistry. pp. 1406-1419. ISSN 0929-8673

(2022) Efficacy and safety of colchicine treatment in patients with COVID-19: A prospective, multicenter, randomized clinical trial. Phytotherapy Research. pp. 891-898. ISSN 0951-418X

(2022) L-carnitine: Searching for New Therapeutic Strategy for Sepsis Management. Current medicinal chemistry. pp. 3300-3323. ISSN 0929-8673

(2022) Pharmacotherapy consideration of thrombolytic medications in COVID-19-associated ARDS. Journal of Intensive Care. p. 20. ISSN 2052-0492

(2021) Aromatic hydrocarbon receptors in mitochondrial biogenesis and function. Mitochondrion. pp. 85-101.

(2021) Efficacy and safety of Levamisole treatment in clinical presentations of non-hospitalized patients with COVID-19: a double-blind, randomized, controlled trial. BMC Infectious Diseases.

(2020) Neutrophil elastase inhibitor (sivelestat) may be a promising therapeutic option for management of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID-19. Journal of Clinical Pharmacy and Therapeutics. pp. 1515-1519. ISSN 0269-4727

(2020) Pharmacological treatments of COVID-19. Pharmacological Reports. pp. 1446-1478. ISSN 1734-1140

(2020) The prophylaxis and treatment potential of supplements for COVID-19. European Journal of Pharmacology. p. 10. ISSN 0014-2999